Page last updated: 2024-08-26

lysophosphatidic acid and Bone Loss, Perimenopausal

lysophosphatidic acid has been researched along with Bone Loss, Perimenopausal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caeiro, JR; Conde, C; Gómez-Reino, JJ; González, A; Guede, D; Martínez, P; Orosa, B1

Other Studies

1 other study(ies) available for lysophosphatidic acid and Bone Loss, Perimenopausal

ArticleYear
Effect of lysophosphatidic acid receptor inhibition on bone changes in ovariectomized mice.
    Journal of bone and mineral metabolism, 2015, Volume: 33, Issue:4

    Topics: Animals; Bone and Bones; Bone Remodeling; Bone Resorption; Calcification, Physiologic; Cell Differentiation; Disease Models, Animal; Female; Femur; Humans; Immunoenzyme Techniques; Isoxazoles; Lysophospholipids; Mice; Mice, Inbred C57BL; Osteoblasts; Osteoclasts; Osteoporosis; Osteoporosis, Postmenopausal; Ovariectomy; Propionates; Receptors, Lysophosphatidic Acid; Signal Transduction; X-Ray Microtomography

2015